93 7533 (Metformin Hydrochloride and Rosiglitazone Maleate 1000 mg / 2 mg)
Pill with imprint 93 7533 is Yellow, Elliptical / Oval and has been identified as Metformin hydrochloride and rosiglitazone maleate 1000 mg / 2 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
Metformin/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/rosiglitazone 1000 mg / 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 93 7533
More about metformin/rosiglitazone
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
- Metformin and rosiglitazone
- Rosiglitazone and Metformin
- Rosiglitazone and metformin (Advanced Reading)
Other brands: Avandamet
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.